Cardiac Safe Transplants for Systemic Sclerosis

Summary

Cardiac Safe Transplants for Systemic Sclerosis is a clinical trial^[1].

Key Facts

• Cardiac Safe Transplants for Systemic Sclerosis is in the country of United States^[2].
• Cardiac Safe Transplants for Systemic Sclerosis's instance of is recorded as clinical trial^[3].
• Cardiac Safe Transplants for Systemic Sclerosis's start time is recorded as +2018-09-07T00:00:00Z^[4].
• Cardiac Safe Transplants for Systemic Sclerosis's end time is recorded as +2025-01-31T00:00:00Z^[5].
• Cardiac Safe Transplants for Systemic Sclerosis's sponsor is recorded as Northwestern University^[6].
• Cardiac Safe Transplants for Systemic Sclerosis's main subject is recorded as sclerosis^[7].
• Cardiac Safe Transplants for Systemic Sclerosis's number of participants is recorded as {'unit': '1', 'amount': '+50'}^[8].
• Cardiac Safe Transplants for Systemic Sclerosis's title is recorded as Autologous Hematopoietic Stem Cell Transplant for Patients With Systemic Sclerosis and Cardiac Dysfunction^[9].
• Cardiac Safe Transplants for Systemic Sclerosis's short name is recorded as CAST^[10].
• Cardiac Safe Transplants for Systemic Sclerosis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Cardiac Safe Transplants for Systemic Sclerosis's ClinicalTrials.gov ID is recorded as NCT03593902^[12].
• Cardiac Safe Transplants for Systemic Sclerosis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[13].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as prednisolone 21-phosphate^[14].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as prednisolone acetate^[15].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as (RS)-cyclophosphamide^[16].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as fludarabine phosphate^[17].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as anti-thymocyte globulin (rabbit)^[18].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as rituximab^[19].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as methylprednisolone hemisuccinate^[20].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as prednisolone^[21].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as methylprednisolone^[22].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as methylprednisolone acetate^[23].
• Cardiac Safe Transplants for Systemic Sclerosis's research intervention is recorded as prednisolone hemisuccinate^[24].
• Cardiac Safe Transplants for Systemic Sclerosis's clinical trial phase is recorded as phase II clinical trial^[25].
• Cardiac Safe Transplants for Systemic Sclerosis's clinical trial phase is recorded as phase III clinical trial^[26].